Chen Jun, Zhang Ting, Luo Qingqing, Wang Ruyi, Dai Yuting, Chen Zhenyuan, Zhang Chutian, Chen Xuzheng, Wu Guangwen
School of Traditional Chinese Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, P.R. China.
Key Laboratory of Orthopedics and Traumatology of Traditional Chinese Medicine and Rehabilitation (Fujian University of Traditional Chinese Medicine), Ministry of Education, Fuzhou, Fujian 350122, P.R. China.
Mol Med Rep. 2025 Aug;32(2). doi: 10.3892/mmr.2025.13581. Epub 2025 May 30.
Following the publication of the above article, the authors have drawn to the Editor's attention that a number of corrections are required to four figures featured in the above article, and a textual change is also required in the Results section. Concerning the textual change, in the last sentence of the first paragraph of the Results on p. 4, "...Schischk and 11 for (Oliv) Diels", should have read as: "...Schischk and for (Oliv) Diels", as shown correctly in Fig. 1C on p. 5. Secondly, concerning the flow cytometric (FCM) data shown in the right‑hand flow chart in the second row of Fig. 5E, the authors have realized that these data were inadvertently copied across from the third flow chart in the first row of Fig. 4C. After examining their original data, the authors have realized that the second flow chart in the second row of Fig. 5E was misplaced (showing the results from the "siPARP1+HO" experiment), and the corrected version of this figure is presented in this corrigendum (the corresponding statistical graph shown in Fig. 5F has been replaced as well). Thirdly, concerning the western blot data shown in Fig. 8 on p. 11, the β‑actin internal reference proteins pertaining to the cleaved‑caspase‑3, PARP1 and cleaved‑PARP1 experiments were selected incorrectly for this figure. These data, and the corresponding statistical graphs shown in Fig. 8A‑D, have been corrected in the new version of Fig. 8 provided in this corrigendum. Fourthly, the FCM flow charts to represent the "3,200 g/ml RJNTF" and "PJ34 inhibitor group" experiments in Fig. 9C on p. 12 were wrongly placed, and both these data and the corresponding statistical graphs have also been corrected in the revised version of Fig. 9 included in this corrigendum. Finally, in Fig. 10 on p. 13, "$" in Fig. 10D (relating to the statistical analysis of the data) should have been written as "ns", and in the corresponding figure legend, "P<0.05 vs. RJNTF group" should have been written as "P<0.05 vs. 1,600 g/ml RJNTF group". These corrections have been attended to in the revised version of Fig. 10 provided in this corrigendum. All the authors approve of the publication of this corrigendum, and the authors are grateful to the Editor of for granting them the opportunity to publish this. The authors regret that these errors were included in the paper, and also apologize to the readership for any inconvenience caused. [Molecular Medicine Reports 29: 102, 2024; DOI: 10.3892/mmr.2024.13226].
上述文章发表后,作者提请编辑注意,上述文章中的四幅图需要进行多处更正,并且结果部分也需要进行文字修改。关于文字修改,在第4页结果部分第一段的最后一句中,“...Schischk and 11 for (Oliv) Diels”应改为:“...Schischk and for (Oliv) Diels”,如第5页图1C所示。其次,关于图5E第二行右侧流程图中显示的流式细胞术(FCM)数据,作者意识到这些数据是无意中从图4C第一行的第三个流程图中复制过来的。在检查原始数据后,作者意识到图5E第二行的第二个流程图位置错误(显示的是“siPARP1+HO”实验的结果),本勘误中给出了该图的正确版本(图5F中显示的相应统计图也已替换)。第三,关于第11页图8中显示的蛋白质印迹数据,该图中与裂解的半胱天冬酶-3、PARP1和裂解的PARP1实验相关的β-肌动蛋白内参蛋白选择错误。这些数据以及图8A-D中显示的相应统计图已在本勘误中提供的图8新版本中进行了更正。第四,图9C(第12页)中代表“3200 g/ml RJNTF”和“PJ34抑制剂组”实验的FCM流程图位置错误,这些数据以及相应的统计图也已在本勘误中包含的图9修订版中进行了更正。最后,在第13页的图10中,图10D(与数据的统计分析有关)中的“$”应改为“ns”,并且在相应的图注中,“P<0.05 vs. RJNTF组”应改为“P<0.05 vs. 1600 g/ml RJNTF组”。这些更正已在本勘误中提供的图10修订版中处理。所有作者均批准发表本勘误,作者感谢《分子医学报告》的编辑给予他们发表此勘误的机会。作者对论文中出现这些错误表示遗憾,并就由此给读者带来的不便向读者致歉。[《分子医学报告》29: 102, 2024; DOI: 10.3892/mmr.2024.13226]